More reads

• Merck's Keytruda lifts survival rates for lung cancer. (Financial Times)
• Grail shows impressive, if early, results for cancer blood test. (STAT)
• The Affordable Care Act erased a racial disparity in health care, a new study says. (STAT)
• AstraZeneca's dynamic duo wants to dominate the market for cancer drugs. (STAT)